Position in TARA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,711,565
-$1,350,543 QoQ
Shares Held
971,614
0.0% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 118 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. TARA ranks #71 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,762,330 | $3,487,217,728 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,801,567 | $2,508,182,547 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
11,443,357 | $2,143,111,898 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,143,131 | $1,150,754,190 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,912,904 | $1,085,696,471 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
8,657,242 | $992,725,940 | |
| 7 | INSM |
INSMED Inc
|
8,796,111 | $937,841,354 | |
| 8 | CELC |
Celcuity Inc.
|
7,915,792 | $828,150,159 |
All Filings in TARA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,711,565 | 971,614 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,062,108 | 971,614 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,178,702 | 971,614 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,335,219 | 536,832 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,626,600 | 536,832 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,286,904 | 536,832 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,834,472 | 536,832 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $982,402 | 536,832 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,116,610 | 536,832 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $800,680 | 199,671 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $374,383 | 199,671 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $333,450 | 199,671 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $477,213 | 199,671 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $624,970 | 199,671 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $535,118 | 199,671 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $591,026 | 199,671 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $585,036 | 199,671 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,020,318 | 199,671 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,347,779 | 199,671 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,381,723 | 199,671 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,944,795 | 199,671 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,142,821 | 199,671 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,834,034 | 199,671 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,360,462 | 199,671 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,854,353 | 199,671 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||